Czechia· CZ-0210064
REVINTY ELLIPTA
A vilanterol und fluticason furoat product containing fluticasone furoate + vilanterol trifenatate, registered in Czechia by GlaxoSmithKline Trading Services Limited, Dublin. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Vilanterol und fluticason furoat is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AK10 (vilanterol und fluticason furoat), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Vilanterol und fluticason furoat · ATC R03AK10
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of vilanterol und fluticason furoat costs, country by country.
Normalised to the WHO defined daily dose (25 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vilanterol und fluticason furoat · price per daily dose (25 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$0.30
The record
At a glance
SÚKL (Czech Republic)- Active substance
- FLUTICASONE FUROATE + VILANTEROL TRIFENATATE
- Manufacturer
- GlaxoSmithKline Trading Services Limited, Dublin
- Country
- Czechia (CZ)
- ATC code
- R03AK10
- ATC class
- Vilanterol und Fluticason furoat
- Defined daily dose
- 25 mcg, Inhal
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for vilanterol und fluticason furoat.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vilanterol und fluticason furoat · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Vilanterol und fluticason furoat in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBreo ElliptaGlaxoSmithKline LLC
- FranceRELVAR ELLIPTA 184 microgrammes/22 microgrammes, poudre pour inhalation, en récipient unidoseGLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- IrelandRelvar Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensedGlaxoSmithKline (Ireland) Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b11fef47-1c0b-4e19-9aed-baaf645a8351 GET /v1/drugs/b11fef47-1c0b-4e19-9aed-baaf645a8351?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INH PLV DOS",
"source": "sukl",
"strength": "184MCG/22MCG",
"pack_size": "1X14DÁV",
"substance": "FLUTICASONE FUROATE + VILANTEROL TRIFENATATE",
"cz_kod_sukl": "0210064",
"product_type": "CH",
"substance_codes": "17738,20312",
"registration_state": "R",
"registration_number": "EU/1/14/929/004"
}See everything about vilanterol und fluticason furoat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.